Rebiotix Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Rebiotix's estimated annual revenue is currently $9.1M per year.
- Rebiotix received $8.5M in venture funding in September 2017.
- Rebiotix's estimated revenue per employee is $155,000
- Rebiotix's total funding is $29.3M.
- Rebiotix has 59 Employees.
- Rebiotix grew their employee count by 26% last year.
- Rebiotix currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Be The Match Bi...||$7.4M||48||26%||N/A||N/A|
|Data Sciences I...||$21.1M||136||N/A||N/A||N/A|
What Is Rebiotix?
Rebiotix Inc is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Heather McDonald||Senior Director Of Manufacturing And Technical Operations||Email Available|
|Lee Jones||CEO/President/Founder||Email Available|
|Heidi Hau||Director, Microbiota Platform Expansion||Email Available|
|Debbie Markus||Sr Director of Quality||Email Available|
|Gary Bezner||Principal Validation Consultant, ValiPro Services LLC||Email Available|
|Amy Parker||Quality Systems and Compliance Manager||Email Available|
|Courtney Jones||Marketing Manager||Email Available|
|Paul Plumb||Director of Clinical Operations at Rebiotix, Inc||Email Available|
|Terry Thomas||Executive Assistant To Chief Executive Officer|
|Nancy Timm||VP Finance & Operations||Email Available|
Rebiotix, a Ferring company, hopes to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.
ROSEVILLE, Minn.--(BUSINESS WIRE)-- Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, ...
Human Microbiome Therapeutics Market 2019 Business Scenario – Enterome Bioscience, Rebiotix, Seres Therapeutics, Vedanta Biosciences.
Rebiotix Executive Hires
|2013-06-05||Ryan Gordon||VP Technical Operations||Article|
|2016-11-29||Ken Blount||Head of External Research||Article|
|2017-06-21||Greg Fluet||Chief Business Officer||Article|
|2017-09-07||Edward Burd||Head of Regulatory Affairs||Article|